03 Sep Scientific Summits conference — Brussels, 22 & 23 October 2021
We have the honour to invite you to the second Scientific Summits conference of 2021, on Friday 22 & Saturday 23 October 2021 in the impressive Wild Gallery in Brussels.
LIVE PRESENCE & ONLINE STREAM
We will welcome as many guests as possible, live in Brussels, obviously taking into account the corona measures applicable at that moment.
To give everyone the opportunity to attend the conference, all sessions will also be recorded and broadcasted online with the help of a high profile technical partner, enabling speakers, attendees & experts to discuss in a virtual ZOOM conference room.
TOP SPEAKERS, TOP CONTENT
As usual, we are proud to once again offer a varied program, with top key opinion leaders & international experts, offering insights into important novelties in the field of urothelial, prostate and kidney cancer.
We look forward to welcoming you, either live or online!
Gert, Steven, Lieven, Karel, Marc, Filip, Christof & Owen
Scientific Summits Board Members
Friday 22 & Saturday 23 October 2021
Hybrid meeting
Wild Gallery in Brussels, Belgium
Scientific program
Friday 22 October 2021
12:00
Lunch
13:00 – 13:15
Start of the event — welcome & introduction
13:15 – 13:45
PART 1 — Bring your own case
Juniors can present too!
13:45 – 17:00
PART 2 — Prostate cancer
Chairs
Prof. Dr. Steven Joniau — UZ Leuven, Belgium
Prof. Dr. Vulsteke Christof — AZ Maria Middelares, Belgium
Dr. François-Xavier Otte — Jules Bordet Instituut Brussels
13:45 – 14:10
The European screening project
Prof. Dr. Hein Van Poppel — UZ Leuven, Belgium
14:10 – 14:35
Elective pelvic radiotherapy in high-risk prostate cancer:
finally ready for prime-time?
Prof. Dr. Alberto Bossi — Institut Gustave Roussy, Paris, France
14:35 – 15:10
Interactive case discussion on (non)-metastatic prostate cancer
Prof. Dr. Steven Joniau & Prof. Dr. Gert De Meerleer — UZ Leuven, Belgium
15:10 – 15:35
Coffee break
15:35 – 16:00
Lutetium-PSMA: where are we?
Prof. Dr. Wouter Vogel — Antoni van Leeuwenhoek, Amsterdam
16:00 – 16:25
Second line hormonal treatment in prostate cancer: real-life cost versus regulatory-defined esteemed cost: too much out of the box?
Prof. Dr. Filip Ameye — AZ Maria Middelares, Gent
16:25 – 16:45
How to improve the availability of new technologies in the current medical landscape?
Marnix Denys — Managing director beMedTech, Belgium
17:00 – 17:45
Mini Symposium
by MSD & AstraZeneca
What do you know about PARPi in the treatment of metastatic prostate cancer?
Prof. Dr. Vulsteke Christof — AZ Maria Middelares, Belgium
18:00
Networking reception
19:00
Congress dinner
Saturday 23 October 2021
09:00 – 11:45
PART 3 — Bladder cancer
Chairs
Prof. Dr. Karel Decaestecker — UZ Gent, Belgium
Prof. Dr. Christof Vulsteke — AZ Maria Middelares, Belgium
Prof. Dr. Valerie Fonteyne — UZ Gent, Belgium
Dr. Simone Albisinni — Hôpital Erasme, Belgium
09:00 – 09:30
How to improve outcomes when focusing on radical cystectomy?
Prof. Dr. Nikhil Vasdev — Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, UK
09:30 – 10:00
Personalized therapy in bladder cancer: the way to improve outcome?
Prof. Dr. Tom Powles — Barts Cancer Centre London, UK
10:00 – 10:30
PET-CT in bladder cancer: ready for prime time?
Prof. Dr. Valerie Fonteyne — UZ Gent, Belgium
10:30 – 10:50
Coffee break
10:50 – 11:40
Mini Symposium
by BMS
High-risk MIUC: need for improving outcomes beyond radical surgery?
Which patients are at high risk of recurrence post radical surgery?
Prof. Dr. Karel Decaestecker — UZ Gent, Belgium
Managing patients with high-risk MIUC beyond radical surgery
Prof. Dr. Christof Vulsteke — AZ Maria Middelares, Belgium
11:45 – 12:45
PART 4 — The outliers in urologic tumors
Chairs
Prof. Dr. Gert De Meerleer — UZ Leuven, Belgium
Prof. Dr. Vulsteke Christof — AZ Maria Middelares, Belgium
Prof. Dr. Steven Joniau — UZ Leuven, Belgium
11:45 – 12:10
Recent advances in non-clear cell kidney cancer
Prof. Dr. Axel Bex — Antoni van Leeuwenhoek, Amsterdam
12:10 – 12:45
Recent advances in treating penile cancer
Prof. Dr. Maarten Albersen — UZ Leuven, Belgium